Werkgroep Cardiologische centra Nederland

CORALreef OUTCOMES (MK0616-015) (Recruiting)

A Phase 3 Randomized, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of MK-0616 in Reducing Major Adverse Cardiovascular Events in Participants at High Cardiovascular Risk
Medicine
MK-0616 (oraal PCSK9-i)
Population
ASCVD
Phase
III
Starting year
2022

Director of Study

dr. L. Kleijn (Cardioloog)
Emmen, Treant Zorggroep, locatie Scheper